ezCaretech Co Ltd is a medical IT company. It specializes in medical information business in domestic medium and large hospitals as well as exporting hospital information system to foreign countries. It offers advanced medical IT solution that computerize all the processes of hospital work change to hospital that boasts outstanding medical services.
2001
n/a
Last FY Revenue $49.4M
Last FY EBITDA $2.6M
$82.5M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
In the most recent fiscal year, ezCaretech achieved revenue of $49.4M and an EBITDA of $2.6M.
ezCaretech expects next 12-month revenue of XXX   and NTM EBITDA of XXX
See ezCaretech valuation multiples based on analyst estimatesNTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|
Revenue | XXX | $49.4M | XXX | XXX | XXX |
Gross Profit | XXX | $8.7M | XXX | XXX | XXX |
Gross Margin | XXX | 18% | XXX | XXX | XXX |
EBITDA | XXX | $2.6M | XXX | XXX | XXX |
EBITDA Margin | XXX | 5% | XXX | XXX | XXX |
EBIT | XXX | $0.2M | XXX | XXX | XXX |
EBIT Margin | XXX | 0% | XXX | XXX | XXX |
Net Profit | XXX | $0.9M | XXX | XXX | XXX |
Net Margin | XXX | 2% | XXX | XXX | XXX |
Net Debt | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, ezCaretech's stock price is KRW 18290 (or $13).
ezCaretech has current market cap of KRW 123B (or $89.4M), and EV of KRW 113B (or $82.5M).
See ezCaretech trading valuation dataEV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
---|---|---|---|---|---|---|
$82.5M | $89.4M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, ezCaretech has market cap of $89.4M and EV of $82.5M.
ezCaretech's trades at 1.6x EV/Revenue multiple, and 117.4x EV/EBITDA.
Equity research analysts estimate ezCaretech's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
ezCaretech's P/E ratio is not available.
See valuation multiples for ezCaretech and 12K+ public compsLTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|---|
Market cap (current) | $89.4M | XXX | $89.4M | XXX | XXX | XXX |
EV (current) | $82.5M | XXX | $82.5M | XXX | XXX | XXX |
EV/Revenue | n/a | XXX | 1.6x | XXX | XXX | XXX |
EV/EBITDA | n/a | XXX | 117.4x | XXX | XXX | XXX |
EV/EBIT | n/a | XXX | -133.0x | XXX | XXX | XXX |
EV/Gross Profit | n/a | XXX | n/a | XXX | XXX | XXX |
P/E | n/a | XXX | -82.5x | XXX | XXX | XXX |
EV/FCF | n/a | XXX | 42.9x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialezCaretech's revenue per employee in the last FY averaged n/a, while opex per employee averaged n/a for the same period.
ezCaretech's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
ezCaretech's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for ezCaretech and other 12K+ public compsLTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|---|
Revenue Growth | n/a | XXX | n/a | XXX | XXX | XXX |
EBITDA Margin | n/a | XXX | n/a | XXX | XXX | XXX |
EBITDA Growth | n/a | XXX | n/a | XXX | XXX | XXX |
Rule of 40 | n/a | XXX | n/a | XXX | XXX | XXX |
Bessemer Rule of X | XXX | XXX | n/a | XXX | XXX | XXX |
Revenue per Employee | XXX | XXX | n/a | XXX | XXX | XXX |
Opex per Employee | XXX | XXX | n/a | XXX | XXX | XXX |
S&M Expenses to Revenue | XXX | XXX | 2% | XXX | XXX | XXX |
G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
R&D Expenses to Revenue | XXX | XXX | 1% | XXX | XXX | XXX |
Opex to Revenue | XXX | XXX | 17% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
EV/Revenue | EV/EBITDA | |||||
---|---|---|---|---|---|---|
2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
Benevolent AI | XXX | XXX | XXX | XXX | XXX | XXX |
Alcidion Group | XXX | XXX | XXX | XXX | XXX | XXX |
CurveBeam AI | XXX | XXX | XXX | XXX | XXX | XXX |
Doctor Care Anywhere | XXX | XXX | XXX | XXX | XXX | XXX |
Echo IQ | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
ezCaretech acquired XXX companies to date.
Last acquisition by ezCaretech was XXXXXXXX, XXXXX XXXXX XXXXXX . ezCaretech acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiplesAcquired Company | EV | EV/Revenue | EV/EBITDA |
---|---|---|---|
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free TrialWhen was ezCaretech founded? | ezCaretech was founded in 2001. |
Where is ezCaretech headquartered? | ezCaretech is headquartered in South Korea. |
Is ezCaretech publicy listed? | Yes, ezCaretech is a public company listed on KRX. |
What is the stock symbol of ezCaretech? | ezCaretech trades under 099750 ticker. |
When did ezCaretech go public? | ezCaretech went public in 2019. |
Who are competitors of ezCaretech? | Similar companies to ezCaretech include e.g. Benevolent AI, Alcidion Group, CurveBeam AI, Doctor Care Anywhere. |
What is the current market cap of ezCaretech? | ezCaretech's current market cap is $89.4M |
Is ezCaretech profitable? | Yes, ezCaretech is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.